Encompass Health Corp
Encompass Health Corp
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 108 | 111 | 72 | 49 | 99 | 96 | 85 | 148 | 154 | 134 | 69 | 100 | |||||
Restricted Cash Current | 26 | 53 | 31 | 45 | 38 | 27 | 38 | 51 | 28 | 38 | 35 | 42 | |||||
Receivables Net Current | 687 | 676 | 619 | 611 | 613 | 623 | 599 | 576 | 590 | 619 | 612 | 536 | |||||
Prepaid Expense Current | - | - | 54 | - | - | - | 42 | - | - | - | 35 | - | |||||
Other Assets Current | 220 | 190 | 130 | 165 | 168 | 165 | 123 | 159 | 166 | 138 | 92 | 137 | |||||
Assets Current | 1,041 | 1,029 | 906 | 870 | 918 | 911 | 887 | 934 | 938 | 930 | 842 | 814 | |||||
Property Plant And Equipment And Finance Lease Rig… | - | 4,217 | 4,102 | 3,926 | 3,820 | 3,724 | 3,643 | 3,524 | 3,439 | 3,370 | 3,301 | 3,186 | |||||
Operating Lease Right Of Use Asset | 198 | 205 | 213 | 218 | 216 | 219 | 204 | 210 | 216 | 199 | 209 | 197 | |||||
Goodwill | 1,324 | 1,318 | 1,318 | 1,303 | 1,303 | 1,284 | 1,284 | 1,284 | 1,284 | 1,281 | 1,281 | 1,281 | |||||
Intangible Assets Net Excluding Goodwill | 307 | 300 | 308 | 292 | 296 | 295 | 298 | 296 | 303 | 272 | 278 | 276 | |||||
Other Assets Noncurrent | 246 | 244 | 244 | 257 | 233 | 210 | 219 | 211 | 208 | 179 | 192 | 210 | |||||
Assets | 7,458 | 7,313 | 7,090 | 6,866 | 6,786 | 6,641 | 6,535 | 6,458 | 6,389 | 6,231 | 6,102 | 5,964 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Long Term Debt And Capital Lease Obligations Curre… | 36 | 43 | 44 | 39 | 139 | 139 | 139 | 233 | 33 | 26 | 25 | 24 | |||||
Operating Lease Liability Current | 28 | 27 | 27 | 26 | 26 | 27 | 26 | 27 | 27 | 25 | 24 | 25 | |||||
Accounts Payable Current | 222 | 204 | 178 | 138 | 175 | 159 | 171 | 170 | 164 | 166 | 170 | 165 | |||||
Employee Related Liabilities Current | - | - | 244 | - | - | - | 228 | - | - | - | 208 | - | |||||
Accrued Liabilities Current | - | - | 55 | - | - | - | 31 | - | - | - | - | - | |||||
Interest Payable Current | - | - | - | - | - | - | 39 | - | - | - | 43 | - | |||||
Other Liabilities Current | 588 | 603 | 290 | 559 | 526 | 532 | 246 | 468 | 471 | 463 | 187 | 425 | |||||
Liabilities Current | 873 | 877 | 836 | 762 | 865 | 856 | 841 | 897 | 695 | 680 | 656 | 639 | |||||
Long Term Debt And Capital Lease Obligations | 2,598 | 2,531 | 2,447 | 2,394 | 2,320 | 2,333 | 2,359 | 2,345 | 2,684 | 2,683 | 2,688 | 2,693 | |||||
Operating Lease Liability Noncurrent | 181 | 189 | 197 | 203 | 201 | 204 | 190 | 196 | 202 | 186 | 196 | 184 | |||||
Self Insurance Reserve Noncurrent | - | - | 153 | - | - | - | 139 | - | - | - | 132 | - | |||||
Deferred Income Tax Liabilities Net | 132 | 135 | 127 | 108 | 111 | 114 | 105 | 97 | 91 | 94 | 87 | 80 | |||||
Other Liabilities Noncurrent | 212 | 215 | 54 | 213 | 201 | 196 | 52 | 198 | 187 | 186 | 46 | 179 | |||||
Liabilities | 3,996 | 3,946 | 3,814 | 3,679 | 3,698 | 3,704 | 3,686 | 3,733 | 3,859 | 3,828 | 3,805 | 3,775 | |||||
Redeemable Noncontrolling Interest Equity Carrying… | 58 | 59 | 58 | 54 | 55 | 56 | 57 | 57 | 49 | 41 | 42 | 42 | |||||
Stockholders Equity Inclu… | |||||||||||||||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | - | - | 1 | - | - | - | 1 | - | - | - | 1 | - | |||||
Additional Paid In Capital | - | - | 1,870 | - | - | - | 1,847 | - | - | - | 1,787 | - | |||||
Retained Earnings Accumulated Deficit | - | - | 1,289 | - | - | - | 797 | - | - | - | 407 | - | |||||
Accumulated Other Comprehensive Income Loss Net Of… | - | - | 1 | - | - | - | 0 | - | - | - | - | - | |||||
Treasury Stock Common Value | - | - | -723 | - | - | - | -578 | - | - | - | -547 | - | |||||
Stockholders Equity | 3,403 | 3,308 | 3,218 | 2,374 | 2,280 | 2,159 | 2,793 | 2,669 | 2,481 | 2,362 | 1,648 | 1,560 | |||||
Minority Interest | 806 | 787 | 779 | 758 | 753 | 722 | 726 | 709 | 642 | 620 | 608 | 587 | |||||
Liabilities And Stockholders Equity | 7,458 | 7,313 | 7,090 | 6,866 | 6,786 | 6,641 | 6,535 | 6,458 | 6,389 | 6,231 | 6,102 | 5,964 | |||||
Variable Interest Entity Primary Beneficiary | - | 206 | 204 | 3 | -0 | 208 | 208 | 10 | -9 | 213 | 208 | 1 | |||||
Common Stock Par Or Stated Value Per Share | - | - | 0.01 | - | - | - | 0.01 | - | - | - | 0.01 | - | |||||
Common Stock Shares Authorized | - | - | 200 | - | - | - | 200 | - | - | - | 200 | - | |||||
Common Stock Shares Issued | - | - | 116 | - | - | - | 116 | - | - | - | 115 | - | |||||
Treasury Stock Common Shares | - | - | 16 | - | - | - | 15 | - | - | - | 15 | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.34% | -8.79% | 4.60% | - | - | - | - | - | - | - | - | - |
| 2025 | 2.55% | 2.79% | -4.98% | 4.55% | 8.79% | 8.47% | 0.44% | -6.55% | -11.57% | -10.58% | -0.56% | -0.33% |
| 2024 | 1.28% | 1.73% | 2.50% | 9.88% | 13.38% | 10.56% | 2.23% | -4.51% | -4.04% | -3.04% | 3.38% | 20.90% |
| 2023 | - | - | - | - | - | - | 5.80% | 7.38% | 12.88% | 2.40% | 6.23% | 14.58% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.19 | 1.17 | 1.08 | 1.14 | 1.06 | 1.06 | 1.05 | 1.04 | 1.35 | 1.37 | 1.28 | 1.27 | |||||
| Quick Ratio | 1.19 | 1.17 | 1.02 | 1.14 | 1.06 | 1.06 | 1.00 | 1.04 | 1.35 | 1.37 | 1.23 | 1.27 | |||||
| Working Capital | 167.60M | 152.30M | 69.50M | 107.80M | 53.00M | 54.90M | 45.90M | 36.50M | 243.60M | 249.50M | 185.40M | 174.50M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 1.17 | 1.19 | 1.19 | 1.55 | 1.62 | 1.72 | 1.32 | 1.40 | 1.56 | 1.62 | 1.69 | 2.42 | |||||
| Interest Coverage TTM | 6.92 | 7.27 | 7.16 | 7.20 | 6.72 | 6.17 | 5.41 | 6.21 | 5.90 | 5.40 | 5.15 | 4.03 | |||||
| Debt Ratio | 0.54 | 0.54 | 0.54 | 0.54 | 0.54 | 0.56 | 0.56 | 0.58 | 0.60 | 0.61 | 0.62 | 0.63 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.87 | 0.87 | 0.87 | 0.87 | 0.86 | 0.86 | 0.85 | 0.84 | 0.83 | 0.83 | 0.82 | 0.82 | |||||
| Days Sales Outstanding TTM | 38.22 | 39.09 | 37.45 | 37.38 | 38.70 | 41.14 | 41.11 | 38.93 | 40.38 | 41.74 | 43.65 | 40.30 | |||||
| Receivables Turnover TTM | 9.55 | 9.34 | 9.75 | 9.76 | 9.43 | 8.87 | 8.88 | 9.38 | 9.04 | 8.74 | 8.36 | 9.06 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 5.33 | 5.61 | 5.54 | 5.92 | 5.65 | 5.29 | 4.46 | 5.65 | 5.32 | 4.77 | 4.57 | 3.11 | |||||
| Free Cash Flow Per Share TTM | 3.93 | 4.56 | 4.25 | 2.63 | 3.00 | 3.84 | 3.61 | 2.70 | 2.18 | 2.47 | 2.80 | 2.73 | |||||
| Dividend Per Share TTM | 0.76 | 0.74 | 0.71 | 0.69 | 0.67 | 0.65 | 0.63 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 48.05% | 47.72% | 47.50% | 47.00% | 46.75% | 46.46% | 58.60% | 71.19% | 84.10% | 97.13% | 97.01% | 96.89% | |||||
| Operating Profit Margin TTM | 16.56% | 16.54% | 16.06% | 15.47% | 15.18% | 14.69% | 13.95% | 13.67% | 13.30% | 12.90% | 12.65% | 12.65% | |||||
| Net Profit Margin TTM | 8.59% | 9.30% | 9.54% | 10.45% | 10.20% | 9.79% | 8.48% | 11.06% | 10.71% | 9.84% | 9.64% | 6.72% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 9.47% | 10.05% | 10.46% | 11.13% | 11.80% | 11.21% | 11.91% | 11.15% | 10.86% | 11.40% | 10.41% | 26.90% | |||||
| Net Income Growth (1Y) | -7.77% | 4.54% | 24.25% | 5.03% | 6.48% | 10.64% | -1.58% | 82.99% | 102.05% | 96.22% | 70.85% | 10.72% | |||||
| EPS Growth (1Y) | -6.09% | 5.91% | 23.51% | 4.40% | 5.74% | 9.87% | -1.97% | 82.26% | 101.24% | 95.43% | 70.33% | 10.38% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 18.69 | 16.94 | 18.73 | 20.93 | 21.16 | 18.67 | 20.00 | 16.51 | 15.54 | 16.63 | 14.09 | 20.79 | |||||
| P/B TTM | 2.93 | 2.89 | 3.30 | 5.34 | 5.36 | 4.67 | 3.26 | 3.57 | 3.40 | 3.43 | 2.89 | 4.20 | |||||
| P/S TTM | 1.61 | 1.58 | 1.79 | 2.19 | 2.16 | 1.83 | 1.70 | 1.83 | 1.66 | 1.64 | 1.36 | 1.40 | |||||
| Market Cap | 9.97B | 9.56B | 10.61B | 12.67B | 12.23B | 10.08B | 9.12B | 9.52B | 8.44B | 8.11B | 6.52B | 6.55B | |||||
| Enterprise Value | 12.49B | 12.02B | 13.03B | 15.01B | 14.55B | 12.45B | 11.49B | 11.95B | 10.97B | 10.69B | 9.13B | 9.13B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 388.20M | 452.00M | 426.80M | 264.70M | 301.30M | 386.40M | 360.30M | 269.50M | 217.70M | 246.70M | 278.60M | 271.60M | |||||
| Net Debt | 2.53B | 2.46B | 2.42B | 2.34B | 2.32B | 2.38B | 2.37B | 2.43B | 2.53B | 2.57B | 2.61B | 2.58B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Encompass Health Corp (EHC) — SEC Financial Statements & Analysis
Encompass Health Corp (EHC) is a services-hospitals company, incorporated in DE. Encompass Health Corp trades on NYSE as: EHC. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Encompass Health Corp reported a 9.47% year-over-year revenue growth, a Gross Profit Margin of 48.05% (TTM), a Debt-to-Equity ratio of 1.17x, a Price-to-Sales (P/S) ratio of 1.61x (TTM), a Price-to-Book (P/B) ratio of 2.93x (TTM), at a market cap of $9.97B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 9.47%
- Gross Profit Margin TTM
- 48.05%
- Debt To Equity
- 1.17x
- P/S TTM
- 1.61x
- P/B TTM
- 2.93x
- Market Cap
- $9.97B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Encompass Health Corp in?
Encompass Health Corp (EHC) operates in the Services-Hospitals industry.
What is EHC's market cap?
Encompass Health Corp (EHC) has a market capitalization of $9.97B as of 2026-06-30.
What is EHC's P/E ratio?
Encompass Health Corp (EHC)'s trailing twelve month P/E ratio is 18.69x as of 2026-06-30.
What exchange does EHC trade on?
Encompass Health Corp (EHC) trades on the NYSE.
Where is Encompass Health Corp incorporated?
Encompass Health Corp is incorporated in DE.